Hepatitis, Toxic
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
412
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Hepatitis, Drug-Induced
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
418
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Drug-Induced Liver Disease
|
phenotype |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
537
|
29
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Colonic Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
947
|
45
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Left-Sided Heart Failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
123
|
5
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Heart Failure, Right-Sided
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
154
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Myocardial Failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
119
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Heart Decompensation
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
113
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Kidney Failure
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
378
|
36
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Drug-Induced Acute Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
413
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Chemical and Drug Induced Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
461
|
38
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Chemically-Induced Liver Toxicity
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
412
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.200 |
None |
1.000 |
1 |
|
2009 |
2009 |
Aneurysm
|
disease |
Cardiovascular Diseases
|
Pathologic Function
|
22
|
36
|
0.200 |
None |
1.000 |
1 |
|
2009 |
2009 |
Reperfusion Injury
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Injury or Poisoning
|
300
|
|
0.200 |
None |
1.000 |
1 |
|
2008 |
2008 |
Diastolic blood pressure
|
phenotype |
|
Clinical Attribute
|
507
|
1037
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Narcolepsy
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
308
|
454
|
0.100 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
Adolescent idiopathic scoliosis
|
disease |
Musculoskeletal Diseases
|
Anatomical Abnormality
|
656
|
1178
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Suntan
|
phenotype |
|
Organ or Tissue Function
|
53
|
94
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3
|
disease |
|
Finding
|
578
|
1158
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Homocysteine measurement
|
phenotype |
|
Laboratory Procedure
|
23
|
33
|
0.100 |
None |
1.000 |
1 |
2
|
2013 |
2013 |
Neoplasms, Neuroepithelial
|
group |
Neoplasms
|
Neoplastic Process
|
46
|
5
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Adult Solid Neoplasm
|
group |
|
Neoplastic Process
|
163
|
3
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Tumor necrosis
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
350
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |